SERUM FERRITIN FOR PREDICTING CLINICALLY RELEVANT LIC THRESHOLDS TO GUIDE MANAGEMENT OF PATIENTS WITH NONTRANSFUSION-DEPENDENT THALASSEMIA TREATED WITH DEFERASIROX: THALASSA STUDY EXTENSION ANALYSIS
暂无分享,去创建一个
M. Cappellini | V. Viprakasit | R. Galanello | A. Taher | N. Siritanaratkul | S. Chuncharunee | A. Kattamis | Z. Karakaş | J. Porter | Zewen Zhu | P. Sutcharitchan | D. Habr